Elham K.
- Country
- Germany
- Department
- Internal Medicine and Infectious Diseases
Research Overview
- Early Switch to Oral Antibiotics Versus Standard Delayed Switch in Adults with Pyogenic Vertebral Osteomyelitis: A Multicenter Randomized Non‑Inferiority Trial (sWITCH‑VO)
- Evaluation of Clindamycin Hydrochloride and Drug Combination on 90-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Data & Insights
Has run more than one trial at 9 of 71 partner sites.
Specializations
Infectious Disease Research
This investigator specializes in the study of Staphylococcus aureus bacteremia, focusing on understanding and treating severe bloodstream infections.
- Bacteremia Management
- Blood-borne Infections
- Systemic Bacterial Infections
The investigator's work centers on developing effective therapeutic approaches for patients with severe bacterial infections.
Clinical Outcomes
The research focus includes investigating mortality outcomes in patients with severe bacterial infections, particularly over extended observation periods.
- Long-term Patient Survival
- Treatment Effectiveness
- Clinical Response Assessment
The investigator evaluates therapeutic interventions and their impact on patient survival rates.
Therapeutic Innovation
Research activities involve studying various therapeutic interventions for bacterial bloodstream infections through adaptive trial platforms.
- Treatment Protocols
- Intervention Strategies
- Clinical Response Patterns
The investigator examines multiple treatment approaches to optimize patient care in severe bacterial infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.